Sharpest tools, in a box: miniature vaccine factories

<p>BioNTech, the German firm behind the first licensed coronavirus jab, reveals its attempts to stuff its technology into <a href="https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/21807708?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners" rel="noopener noreferrer" target="_blank">shipping containers</a>—to be used where they are most needed. In the second instalment of our French-election series, we ask <a href="https://www.economist.com/europe/2022/01/13/the-french-left-faces-disaster-in-aprils-presidential-election?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners" rel="noopener noreferrer" target="_blank">what is left</a> of the country’s left. And, as the Olympics wrap up, putting numbers to judges' <a href="https://www.economist.com/graphic-detail/2022/02/12/how-to-detect-nationalism-in-winter-sport-judges?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners" rel="noopener noreferrer" target="_blank">biases</a> that favour their compatriots.&nbsp;</p><p>For full access to print, digital and audio editions of <em>The Economist</em>, subscribe here <a href="http://www.economist.com/intelligenceoffer" rel="noopener noreferrer" target="_blank">www.economist.com/intelligenceoffer</a></p><hr /><p style="color: grey; font-size: 0.75em;"> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color: grey;" target="_blank">acast.com/privacy</a> for more information.</p>